下一个

自动播放

Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma

2 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放